Mirco Meniconi Email

Director Computational Sciences . Dunad Therapeutics

Current Roles

Employees:
35
Revenue:
$2.7M
About
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted oral protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable and CNS-accessible protein degraders.
Dunad Therapeutics Address
125 Old Broad Street
Cambridge, Cambridge
Dunad Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.